Doudou Zhang

Nanjing, 210093, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models.

A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models.

Journal: Science translational medicine

Published: November 19, 2025

Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain.

Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain.

Journal: PLoS pathogens

Published: May 16, 2024

Systemic administration of a potent mouse monoclonal antibody provides multisite protection against HPV16 infection.

Systemic administration of a potent mouse monoclonal antibody provides multisite protection against HPV16 infection.

Journal: International immunopharmacology

Published: March 17, 2024

Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration.

Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration.

Journal: Nature communications

Published: October 30, 2023

Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody.

Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody.

Journal: EMBO molecular medicine

Published: September 04, 2023

Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22).

Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22).

Journal: Frontiers in immunology

Published: January 29, 2022

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer.

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer.

Journal: Frontiers in immunology

Published: March 09, 2021

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration.

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration.

Journal: Cell reports

Published: March 03, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026